Titan Pharmaceuticals Reports Third Quarter 2016 Financial Results

Go back to Titan Pharmaceuticals Reports Third Quarter 2016 Financial Results

Titan Pharma (TTNP) Misses Q3 EPS by 1c

November 9, 2016 8:34 AM EST

Titan Pharma (NASDAQ: TTNP) reported Q3 EPS of ($0.12), $0.01 worse than the analyst estimate of ($0.11).

For earnings history and earnings-related data on Titan Pharma (TTNP) click here.

... More